Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in biomarkers research, from development and diagnostics to precision medicine

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Diagnostics

Diagnostic Biomarkers Discovered for Lyme Disease

New hope raised for the early detection and treatment of the tick-borne illness.
Read More
Diagnostics

Predicting Heart Disease Risk with ‘Good’ Cholesterol: Is it Still Viable?

A new study analysing the cholesterol levels of black adults challenges traditional perceptions of its role in predicting heart disease risk.
Read More
Biomarker Technologies

Breath Biopsy Omni For Comprehensive & Reliable Detection Of VOC Biomarkers In Breath

On-Demand Webinar featuring Dr Elizabeth Crone, Business Development Manager at Owlstone & Dr Hsuan (Tina) Chou, Biomarker Scientist at Owlstone
Read More
Biomarkers for Clinical Development

Toxicity Markers of Cognitive Deterioration in Young Cancer Sufferers

Cancer-related cognitive impairment in young adults found pre-treatment, study reports.
Read More
Biomarker Technologies

Are Neuroimmune Proteins the Key to Neurodegenerative Disease Diagnosis?

Unique neuroinflammatory signatures and pathways present in tauopathies could provide greater insight into distinct mechanisms of disease.
Read More
Biomarkers for Clinical Development

Implementing Patient-Centricity into Biomarker Clinical Trials

How can we better define patient-centric clinical trials within the drug development process?
Read More
Biomarkers for Clinical Development

Cervical Indicators of HIV Risk Found

Study finds predictive link between genital herpes and HIV.
Read More
Diagnostics

Predicting Preeclampsia Risk with Placental Proteins

A new study by Cedars-Sinai could identify protein biomarkers for preeclampsia.
Read More
Biomarkers for Clinical Development

Novel Microbial Immunotherapies for Bladder Cancer Treatment

The potential oncolytic applications of Salmonella ZH9 include its use in mitigating diseases such as bladder cancer, with a demonstrated therapeutic effect in cancer models.
Read More
Biomarkers for Clinical Development

Patient Engagement in Biomarker Development

Christopher Conn, Director of Diagnostics Strategy at Amgen, leads a Discussion Group on patient testing and engagement in biomarker clinical trials.
Read More
Biomarker Technologies

Biomarker Testing Consolidation and Implementation Using Multiplex Immunofluorescence

Multiplex immunofluorescence is gaining prevalence in oncology diagnostics; what makes it so effective, and how is it being brought into the clinic?
Read More
Biomarkers for Clinical Development

Biomarkers for NASH Symposium: Most Anticipated Presentation

Discover key event highlights from Oxford Global's upcoming Biomarkers for NASH Symposium 2022.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biomarkers